Related Experiment Video
Updated: May 13, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
Leveraging Social Risk Factor Screening Infrastructure in Rheumatology Clinics to Respond to Rising Rates of
Rebecca Summit1, Dylan B Tierney2,3,4,5, Taussia Boadi1
1Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Objective:
Immunocompromised individuals with rheumatic conditions have heightened risk of tuberculosis (TB) infection, reactivation, and severe disease. Patients with social risks are especially vulnerable. After an alert of increased TB rates among individuals experiencing homelessness in Massachusetts, we leveraged the existing social risk screening infrastructure to identify those at highest risk.
Methods:
We identified patients with rheumatic conditions receiving immunosuppressive or immunomodulatory medications and recent housing instability from the electronic health records (EHRs) of a multihospital medical system. We notified these patients' rheumatologists and provided latent TB and TB symptom screening information. We tracked EHR documentation, orders, and laboratory results following this alert.
Results:
Thirty-three patients with rheumatic conditions experienced housing instability. Of these, 23 (70%) patients cared for by 17 rheumatologists were prescribed ≥1 immunosuppressive or immunomodulatory medications. Following the alert, three (13%) patients had EHR documentation of symptom screening, one provider responded that their patient was not homeless, and one ordered an interferon-gamma release assay ("T-SPOT"). After the reminder, seven (30%) T-SPOT tests were ordered, five (22%) patients had EHR documentation of symptom review at their subsequent rheumatology appointment, and four (18%) patients were messaged by their rheumatologists about their TB risk.
Conclusion:
The existing rheumatology-based social risk factor screening infrastructure facilitated a rapid response to a relevant public health concern. Rheumatologists' responses varied, possibly due to increased clinical stressors with limited support. Despite challenges to reaching patients with housing instability, many actions were taken. Efforts to prompt regular TB screening of patients with these vulnerabilities are underway.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Rheumatic Heart Disease III: Medical Management